Showing results (171-180 of 265) with videos related to

Sort By:
Pageof 27
The Journal of Bone and Joint Surgery. American Volume|March 11, 2022
Conceptualizing Biological Aging and Frailty in Orthopaedics: A Framework for Clinical PracticeTing Cong, Arielle J Hall, Zhimeng Jia, et al.
Diabetes, Obesity & Metabolism|October 9, 2012
XMetA, an allosteric monoclonal antibody to the insulin receptor, improves glycaemic control in mice with diet-induced obesityV Bhaskar, A Lau, I D Goldfine, et al.
Oncogene|August 3, 1995
Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cellsG M Marshall, B Cheung, K P Stacey, et al.
Archives of Oral Biology|March 18, 2014
Angiotensin II induces mitochondrial dysfunction and promotes apoptosis via JNK signalling pathway in primary mouse calvaria osteoblastGuangyue Li, Min Wang, Liang Hao, et al.
Molecules (Basel, Switzerland)|July 19, 2016
Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline MoietyMurat Bingul, Owen Tan, Christopher R Gardner, et al.
Frontiers in Genetics|August 10, 2019
Increase in DNA Damage by MYCN Knockdown Through Regulating Nucleosome Organization and Chromatin State in NeuroblastomaXinjie Hu, Weisheng Zheng, Qianshu Zhu, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 19, 2013
The Functional Living Index-Cancer is a reliable and valid instrument in Chinese cancer patientsDaniel Y T Fong, Alvina H K Lee, Stewart Y Tung, et al.
Spine|June 26, 2018
Outcomes and Complications Following Laminectomy Alone for Thoracic Myelopathy due to Ossified Ligamentum Flavum: A Systematic Review and Meta-AnalysisNebiyu S Osman, Zoe B Cheung, Awais K Hussain, et al.
Archives of Oral Biology|November 27, 2010
Angiotensin II induces interleukin-6 synthesis in osteoblasts through ERK1/2 pathway via AT1 receptorLing Guo, Min Wang, Zhi-yi Zhang, et al.
Vaccine|May 5, 2011
Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 monthsF M Russell, A Balloch, P V Licciardi, et al.
Pageof 27